Publicaciones
Novel catalytically-inactive PII metalloproteinases from a viperid snake venom with substitutions in the canonical zinc-binding motif.
Publicado en: Toxins 8: 292.
From fangs to pharmacology: The future of snakebite envenoming therapy.
Publicado en: Current Pharmaceutical Design 22: 5270-5293.
Proteomics and antivenomics of Papuan black snake (Pseudechis papuanus) venom with analysis of its toxicological profile and the preclinical efficacy of Australian antivenoms.
Publicado en: Journal of Proteomics 150: 201-215.
The need for an integrated approach in confronting snakebite envenoming in Latin America: The relevance of endogenous scientific and technological research.
Publicado en: Vitae (Colombia) 23: 103-105.
Venoms of Micrurus coral snakes: Evolutionary trends in compositional patterns emerging from proteomic analysis.
Publicado en: Toxicon 122: 7-25.
Exploring the venom of the forest cobra snake: Toxicovenomics and antivenom profiling of Naja melanoleuca.
Publicado en: Journal of Proteomics 150: 98-108.
Biochemical and biological characterization of Bothriechis schlegelii snake venoms from Colombia and Costa Rica.
Publicado en: Experimental Biochemistry and Medicine 241: 2075-2085.
Development of a chicken-derived antivenom against the taipan snake (Oxyuranus scutellatus) venom and comparison with an equine antivenom.
Publicado en: Toxicon 120: 1-8.
Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics.
Publicado en: Toxicon 119: 280-288.
Lemnitoxin, the major component of Micrurus lemniscatus coral snake vneom, is a myotoxic and pro-inflammatory phospholipase A2.
Publicado en: Toxicology Letters 257: 60-71.